BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21611749)

  • 1. XPA A23G polymorphism and lung cancer risk: a meta-analysis.
    Zou JH; An L; Chen S; Ren LQ
    Mol Biol Rep; 2012 Feb; 39(2):1435-40. PubMed ID: 21611749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis on the association between xeroderma pigmentosum Group A A23G polymorphism and esophageal cancer in a Chinese population.
    Xu JL; Bai J; Jiao JF; Ding L; Lei L; Bai XP; Cheng YF
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1173-S1177. PubMed ID: 30539866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between XPA gene rs1800975 polymorphism and susceptibility to lung cancer: a meta-analysis.
    Liu X; Lin Q; Fu C; Liu C; Zhu F; Liu Z; Li S; Jiang L
    Clin Respir J; 2018 Feb; 12(2):448-458. PubMed ID: 27460688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of XPA Polymorphisms Towards Lung Cancer Susceptibility and its Predictive Role in Overall Survival of North Indians.
    Lawania S; Singh N; Behera D; Sharma S
    Biochem Genet; 2018 Aug; 56(4):375-396. PubMed ID: 29516319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation of XPA gene and risk of cancer: a systematic review and pooled analysis.
    Ding D; Zhang Y; Yu H; Guo Y; Jiang L; He X; Ma W; Zheng W
    Int J Cancer; 2012 Jul; 131(2):488-96. PubMed ID: 21866550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
    Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
    Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis.
    Gu M; Dong X; Zhang X; Wang X; Qi Y; Yu J; Niu W
    PLoS One; 2012; 7(6):e37970. PubMed ID: 22701590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis.
    He L; Deng T; Luo H
    Onco Targets Ther; 2015; 8():385-94. PubMed ID: 25709470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
    Zhou C; Luo Q; Qing Y; Lin X; Zhan Y; Ouyang M
    Tumour Biol; 2013 Dec; 34(6):3449-55. PubMed ID: 23943394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 -251A/T gene polymorphism and lung cancer susceptibility: a meta-analysis.
    Wang XB; Li YS; Li J; Han Y; Liu ZD
    J Cell Mol Med; 2015 Jun; 19(6):1218-22. PubMed ID: 25817779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of XPA polymorphism with breast cancer risk: A meta-analysis.
    Zhang Y; Guo Q; Yin X; Zhu X; Zhao L; Zhang Z; Wei R; Wang B; Li X
    Medicine (Baltimore); 2018 Jun; 97(26):e11276. PubMed ID: 29953005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHRNA5 rs16969968 polymorphism is associated with lung cancer risk: A meta-analysis.
    Zhou W; Zhu W; Tong X; Ming S; Ding Y; Li Y; Li Y
    Clin Respir J; 2020 Jun; 14(6):505-513. PubMed ID: 32049419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
    Xie M; Zhao F; Zou X; Jin S; Xiong S
    Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
    Li Y; Qiu LX; Shen XK; Lv XJ; Qian XP; Song Y
    Lung Cancer; 2009 Oct; 66(1):15-21. PubMed ID: 19178978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPA gene rs1800975 single nucleotide polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Zhang Y; Zhong R; Pei J; Xiong L; Zhang X; Han B
    Tumour Biol; 2014 Jul; 35(7):6607-17. PubMed ID: 24696258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.
    Han D; Shen C; Meng X; Bai J; Chen F; Yu Y; Jin Y; Fu S
    Mol Biol Rep; 2012 Feb; 39(2):805-16. PubMed ID: 21547363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFalpha -308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls.
    Fang F; Yao L; Yu XJ; Yu L; Wu Q; Yu L
    Breast Cancer Res Treat; 2010 Jul; 122(1):267-71. PubMed ID: 20035378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
    Ma Q; Qi C; Tie C; Guo Z
    Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SNP rs402710 in 5p15.33 is associated with lung cancer risk: a replication study in Chinese population and a meta-analysis.
    Lu X; Ke J; Luo X; Zhu Y; Zou L; Li H; Zhu B; Xiong Z; Chen W; Deng L; Lou J; Wang X; Zhang Y; Wang Z; Miao X; Cheng L
    PLoS One; 2013; 8(10):e76252. PubMed ID: 24194831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.